(Total Views: 675)
Posted On: 07/27/2020 8:46:03 PM
Post# of 145890
Quite the study for Regenreron's dual spike-protein antibodies.
Integrated Phase 1 / Phase 2 / Phase 3 design
2,580 total patients, 39 sites now open.
Must not be confident of a big effect if they need that many patients.
Integrated Phase 1 / Phase 2 / Phase 3 design
2,580 total patients, 39 sites now open.
Must not be confident of a big effect if they need that many patients.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)